VeloClub is CyclingTips’ membership program which brings us closer to our members, and connects likeminded cycling enthusiasts.
by Shane Stokes
February 14, 2018
Coquard wins stage 1 of the Tour of Oman; Report: Froome anti-doping hearing may take place in the coming days; Scarponi investigation closed after driver involved in collision dies; Opinion: Time for Chris Froome and Sky to rebuild the people’s trust; Mountainous Rás Tailteann route unveiled; CyclingTips Podcast: The world’s slowest wheel change and a bit of world politics; Audio: Rás legend Gaybo Howard remembered in entertaining interview; Video: UAE Team Emirates – Wind tunnel test; Video: Inertia ft. Brandon Semenuk;
With Chris Froome due to begin racing on Wednesday in the Vuelta a Andalucia/Ruta del Sol, La Gazzetta dello Sport has reported that his ongoing case is set to be held in the coming days by the UCI Anti-Doping tribunal. It said that the hearing will begin at some point from the end of this week or the start of next week.
On December 13 The Guardian and Le Monde revealed that a urine sample provided by Froome after stage 18 of the Vuelta a Espana contained twice the maximum permitted level of salbutamol.
Froome denied all wrongdoing, saying that he didn’t exceed the maximum allowed amount of inhalations of his asthma medication. However, thus far, hasn’t explained how the adverse analytical finding happened. He will need to do so to the UCI tribunal. In recent weeks it was reported that he may claim that his kidneys failed to clear the substance properly, with backlogged traces then being released and triggering the result.
Riders who previously tested positive for excessive amounts of Salbutamol, such as Diego Ulissi and Alessandro Petacchi, all faced long bans from competition. Froome risks the same and, because he didn’t accept a voluntary suspension, it appears possible that he could miss both this year’s Giro d’Italia and the Tour de France.
He could also face the loss of his Vuelta a Espana title.